A trial of rebamipide for the healing of artificial ulcers after endoscopic submucosal dissection.

A trial of rebamipide for the healing of artificial ulcers after endoscopic submucosal dissection. - Rebamipide for artificial ulcers after endoscopic submucosal dissection.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000011715

Enrollment

Registered

2013-09-11

Start date

2011-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric tumor

Interventions

omeprazol group omepurazol and rebamipide group

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 20-80 years old patients for endocopic resection

Exclusion criteria

Exclusion criteria: Patients with partial gastrectomy severe heart disease

Design outcomes

Primary

Measure	Time frame
The rate of ulcer healing by rebamipide 8 W after ESD.	—

Countries

Japan

Contacts

Public ContactJun Nishikawa

Yamaguchi University Graduate School of Medicine Department of gastroenterology

junnis@yamaguchi-u.ac.jp0836-22-2241

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026